Dmitriy Sonkin
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
Papers in
-
- RNA modifications and cancer 5
- Wnt/β-catenin signaling in development and cancer 3
- Epigenetics and DNA Methylation 3
-
- Cancer Genomics and Diagnostics 14
- Co-authors
- Beverly A. Teicher (6 shared papers)Jiří Zavadil (2 shared papers)Monica Hollstein (1 shared paper)Maude Ardin (2 shared papers)Magali Olivier (2 shared papers)Liacine Bouaoun (2 shared papers)Graham Byrnes (2 shared papers)Anish Thomas (2 shared papers)
- Journals
- Human Mutation (5 papers)Cancer Research (3 papers)Proceedings of the National Academy of Sciences (2 papers)Clinical Epigenetics (1 paper)Molecular Oncology (1 paper)
- Partner nations
- United StatesMalaysiaSwitzerland
In The Last Decade
Dmitriy Sonkin
29 papers receiving 1.4k citations
Dmitriy Sonkin's Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 450
- Oncology 640
- Molecular Biology 845
- Pathology and Forensic Medicine 132
- Biotechnology 56
Countries citing papers authored by Dmitriy Sonkin
This map shows the geographic impact of Dmitriy Sonkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitriy Sonkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitriy Sonkin more than expected).
Fields of papers citing papers by Dmitriy Sonkin
This network shows the impact of papers produced by Dmitriy Sonkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitriy Sonkin. The network helps show where Dmitriy Sonkin may publish in the future.
Co-authors
The 25 scholars most cited alongside Dmitriy Sonkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data Hit paper breakdown → | 2016 | 536 |
| 2 | Cancer treatments: Past, present, and future Hit paper breakdown → | 2024 | 192 |
| 3 | 2016 | 106 | |
| 4 | 2013 | 90 | |
| 5 | 2011 | 85 | |
| 6 | 2020 | 50 | |
| 7 | 2009 | 45 | |
| 8 | 2016 | 42 | |
| 9 | 2014 | 28 | |
| 10 | 2018 | 27 | |
| 11 | 2013 | 25 | |
| 12 | 2019 | 22 | |
| 13 | 2016 | 19 | |
| 14 | 2008 | 19 | |
| 15 | 2015 | 17 | |
| 16 | 2017 | 16 | |
| 17 | 2018 | 12 | |
| 18 | 2017 | 12 | |
| 19 | 2017 | 12 | |
| 20 | 2019 | 7 |
About Dmitriy Sonkin
Dmitriy Sonkin is a scholar working on Molecular Biology, Cancer Research, Oncology, Genetics and Pathology and Forensic Medicine, having authored 31 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (14 papers), Cancer-related Molecular Pathways (6 papers), RNA modifications and cancer (5 papers), Genomics and Rare Diseases (5 papers), Genetic factors in colorectal cancer (4 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Epigenetics and DNA Methylation (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Cancer Research (450 citations), Oncology (640 citations), Molecular Biology (845 citations), Pathology and Forensic Medicine (132 citations) and Biotechnology (56 citations). Dmitriy Sonkin has collaborated with scholars based in United States, Malaysia and Switzerland. Frequent co-authors include Beverly A. Teicher, Jiří Zavadil, Monica Hollstein, Maude Ardin, Magali Olivier, Liacine Bouaoun, Graham Byrnes, Anish Thomas, David M. Evans and Thomas Silvers. Their work appears in journals such as Human Mutation, Cancer Research, Proceedings of the National Academy of Sciences, Clinical Epigenetics and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.